Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3
<p>Many tumour causing proteins, such as those expressed after chromosomal translocations or from point mutations, are intracellular and are not enzymes <em>per se</em> amenable to conventional drug targeting. We previously demonstrated an approach (<u>A</u>ntibody-anti...
Main Authors: | Chambers, J, Brend, T, Rabbitts, T |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Nature Research
2019
|
Podobne knjige/članki
-
Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.
od: Tse, E, et al.
Izdano: (2000) -
Intracellular antibody capture (IAC) methods for single domain antibodies.
od: Tanaka, T, et al.
Izdano: (2012) -
Cancer cell killing using engineered intracellular antibody fragments
od: Chambers, J
Izdano: (2018) -
Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies.
od: Tanaka, T, et al.
Izdano: (2003) -
Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.
od: Tanaka, T, et al.
Izdano: (2010)